ArticleMilitary Medical Research2026

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.